Details of the Drug Reposition

General Information of This Drug (ID: DM7SAKN)

Drug Name
Rostaporfin   DM7SAKN
Synonyms Photrex; Purlytin; Rostaporfine; Tin ethyl etiopurpurin dichloride; Tin etiopurpurin dichloride; Photopoint SnET2; SnET2; PNU-167524; PNU-524-OPT-0065
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Macular degeneration DISLKKHD 9B78.3 Phase 3 [1]
------------------------------------------------------------------------------------
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Breast cancer DIS7DPX1 2C60-2C65 Phase 2 [2]
------------------------------------------------------------------------------------
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 1 [2]
Basal cell carcinoma DIS7PYN3 2C32 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT00157976) Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)